Showing results (161-170 of 168) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Lancet (London, England)|January 24, 2021
Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trialStephanie Lheureux, Mihaela C Cristea, Jeffrey P Bruce, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial)Husam A Alqaisi, David E Cohn, Jing-Yi Chern, et al.Genome Medicine|October 27, 2016
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trialTracy L Stockley, Amit M Oza, Hal K Berman, et al.Science Translational Medicine|March 24, 2012
Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibioticsChristopher M Tan, Alex G Therien, Jun Lu, et al.Neurobiology of Aging|November 6, 2016
Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter studyLisa Wang, Michael G Heckman, Jan O Aasly, et al.Cancer Immunology, Immunotherapy : CII|February 13, 2019
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2Linh T Nguyen, Samuel D Saibil, Valentin Sotov, et al.Neurology|September 11, 2015
Large-scale assessment of polyglutamine repeat expansions in Parkinson diseaseLisa Wang, Jan O Aasly, Grazia Annesi, et al.Science (New York, N.Y.)|October 31, 2024
Brain malformations and seizures by impaired chaperonin function of TRiCFlorian Kraft, Piere Rodriguez-Aliaga, Weimin Yuan, et al.Pageof 17